Finzati - Logo
ICLR logo

ICON Public Limited Company

ICLR • Medical - Diagnostics & Research
$164.85
▲ +1.27 (+0.78%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$10.92B
Growth
13.5%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 6.5%Positive free cash flow · 10.99Consistent free cash flow · 5/5Manageable debt level · 0.39Expensive earnings multiple · 62.31
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$164.85
Change0.78%
Market Cap$10.92B
52W Range66.57 - 211.00
Beta1.27
Gross Margin26.37%
Oper. Margin12.27%
Profit Margin2.78%
Debt/Eq0.39
Current Ratio1.10
Quick Ratio1.10
Revenue 5Y13.52%

Investment DNA

How strong this company looks for long-term investors

63
out of 100
Business Quality
Margins, moat, returns
39/100
Financial Strength
Debt, cash, stability
69/100
Growth Potential
Revenue and expansion
56/100
Price Attractiveness
Cheap or expensive today
65/100
Why this score▼
Positive revenue growth · 6.5%Positive free cash flow · 10.99Consistent free cash flow · 5/5Manageable debt level · 0.39Expensive earnings multiple · 62.31Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$100.00
Mean
$141.73
Median
$145.00
High
$216.00

Company Overview

IPO: 5/15/1998
Industry: Medical - Diagnostics & Research
P/B i: 1.55
Debt / Equity i: 0.39
Operating Margin: 12.27%
Net Margin: 2.78%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.39
Current Ratio: 1.10
Quick Ratio: 1.10
Status: Good

Insider Transactions

Recent executive and insider activity

Elliott Jeffrey Thomas
Transaction: 06/01/2026
OTHER
Change
0
Price
Not reported
Filing
06/05/2026
Type
OTHER
Egan Kevin Francis
Transaction: 06/01/2026
OTHER
Change
0
Price
Not reported
Filing
06/05/2026
Type
OTHER
McCague Eugene Pacelli
Transaction: 05/14/2026
SELL
Change
-3,255
Price
$125.74
Filing
05/15/2026
Type
SELL